ATP stimulated cyclic AMP formation in bovine chromaffin cells is enhanced by neuropeptide Y

Peijin Zhang, Jialin C Zheng, Michael E. Bradley, Terry D. Hexum

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

ATP increases cAMP formation in bovine chromaffin cells, EC50 = 7.1 × 10-6 M. NPY, EC50 = 4.1 × 10-8 M, increases the efficacy of ATP (1.5-2 fold). Inclusion of the selective Y1 receptor antagonist 1229U91 produced a decrease in NPY potency (EC50 = 2.7 × 10-7 M). PTX pretreatment did not abolish either the effect of ATP nor the enhancement by NPY. NPY could also enhance the ability of angiotensin and bradykinin to increase cAMP formation. The selective phospholipase C inhibitor, U73122, and the selective protein kinase C inhibitors, bisindolylmaleimide I and RO-31-8425, were effective inhibitors of the enhancing effect of NPY.

Original languageEnglish (US)
Pages (from-to)439-444
Number of pages6
JournalPeptides
Volume22
Issue number3
DOIs
StatePublished - Apr 11 2001

Fingerprint

Chromaffin Cells
Neuropeptide Y
Cyclic AMP
Adenosine Triphosphate
Protein C Inhibitor
Angiotensins
Type C Phospholipases
Bradykinin
Protein Kinase Inhibitors
Protein Kinase C

Keywords

  • Chromaffin cell
  • Crosstalk
  • G protein
  • Receptor
  • Signaling

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Cellular and Molecular Neuroscience

Cite this

ATP stimulated cyclic AMP formation in bovine chromaffin cells is enhanced by neuropeptide Y. / Zhang, Peijin; Zheng, Jialin C; Bradley, Michael E.; Hexum, Terry D.

In: Peptides, Vol. 22, No. 3, 11.04.2001, p. 439-444.

Research output: Contribution to journalArticle

Zhang, Peijin ; Zheng, Jialin C ; Bradley, Michael E. ; Hexum, Terry D. / ATP stimulated cyclic AMP formation in bovine chromaffin cells is enhanced by neuropeptide Y. In: Peptides. 2001 ; Vol. 22, No. 3. pp. 439-444.
@article{4da5985921704c4cbcc7d2065ee4acf0,
title = "ATP stimulated cyclic AMP formation in bovine chromaffin cells is enhanced by neuropeptide Y",
abstract = "ATP increases cAMP formation in bovine chromaffin cells, EC50 = 7.1 × 10-6 M. NPY, EC50 = 4.1 × 10-8 M, increases the efficacy of ATP (1.5-2 fold). Inclusion of the selective Y1 receptor antagonist 1229U91 produced a decrease in NPY potency (EC50 = 2.7 × 10-7 M). PTX pretreatment did not abolish either the effect of ATP nor the enhancement by NPY. NPY could also enhance the ability of angiotensin and bradykinin to increase cAMP formation. The selective phospholipase C inhibitor, U73122, and the selective protein kinase C inhibitors, bisindolylmaleimide I and RO-31-8425, were effective inhibitors of the enhancing effect of NPY.",
keywords = "Chromaffin cell, Crosstalk, G protein, Receptor, Signaling",
author = "Peijin Zhang and Zheng, {Jialin C} and Bradley, {Michael E.} and Hexum, {Terry D.}",
year = "2001",
month = "4",
day = "11",
doi = "10.1016/S0196-9781(01)00354-0",
language = "English (US)",
volume = "22",
pages = "439--444",
journal = "Peptides",
issn = "0196-9781",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - ATP stimulated cyclic AMP formation in bovine chromaffin cells is enhanced by neuropeptide Y

AU - Zhang, Peijin

AU - Zheng, Jialin C

AU - Bradley, Michael E.

AU - Hexum, Terry D.

PY - 2001/4/11

Y1 - 2001/4/11

N2 - ATP increases cAMP formation in bovine chromaffin cells, EC50 = 7.1 × 10-6 M. NPY, EC50 = 4.1 × 10-8 M, increases the efficacy of ATP (1.5-2 fold). Inclusion of the selective Y1 receptor antagonist 1229U91 produced a decrease in NPY potency (EC50 = 2.7 × 10-7 M). PTX pretreatment did not abolish either the effect of ATP nor the enhancement by NPY. NPY could also enhance the ability of angiotensin and bradykinin to increase cAMP formation. The selective phospholipase C inhibitor, U73122, and the selective protein kinase C inhibitors, bisindolylmaleimide I and RO-31-8425, were effective inhibitors of the enhancing effect of NPY.

AB - ATP increases cAMP formation in bovine chromaffin cells, EC50 = 7.1 × 10-6 M. NPY, EC50 = 4.1 × 10-8 M, increases the efficacy of ATP (1.5-2 fold). Inclusion of the selective Y1 receptor antagonist 1229U91 produced a decrease in NPY potency (EC50 = 2.7 × 10-7 M). PTX pretreatment did not abolish either the effect of ATP nor the enhancement by NPY. NPY could also enhance the ability of angiotensin and bradykinin to increase cAMP formation. The selective phospholipase C inhibitor, U73122, and the selective protein kinase C inhibitors, bisindolylmaleimide I and RO-31-8425, were effective inhibitors of the enhancing effect of NPY.

KW - Chromaffin cell

KW - Crosstalk

KW - G protein

KW - Receptor

KW - Signaling

UR - http://www.scopus.com/inward/record.url?scp=0035094571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035094571&partnerID=8YFLogxK

U2 - 10.1016/S0196-9781(01)00354-0

DO - 10.1016/S0196-9781(01)00354-0

M3 - Article

VL - 22

SP - 439

EP - 444

JO - Peptides

JF - Peptides

SN - 0196-9781

IS - 3

ER -